These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8942079)

  • 1. Allorecognition by murine natural killer cells: studies with bone marrow transplants and lysis of T lymphoblasts.
    Liu J; Yu YY; Lindahl KF; Kumar V; Bennett M
    Chem Immunol; 1996; 64():164-80. PubMed ID: 8942079
    [No Abstract]   [Full Text] [Related]  

  • 2. Allorecognition by murine natural killer cells: lysis of T-lymphoblasts and rejection of bone-marrow grafts.
    George T; Yu YY; Liu J; Davenport C; Lemieux S; Stoneman E; Mathew PA; Kumar V; Bennett M
    Immunol Rev; 1997 Feb; 155():29-40. PubMed ID: 9059880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.
    Roberts MR; Cooke KS; Tran AC; Smith KA; Lin WY; Wang M; Dull TJ; Farson D; Zsebo KM; Finer MH
    J Immunol; 1998 Jul; 161(1):375-84. PubMed ID: 9647246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural resistance to foreign hemopoietic transplants: a possible model of leukemia surveillance.
    Lotzová E; Savary CA
    Prog Clin Biol Res; 1983; 132C():125-35. PubMed ID: 6356143
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural killer defined haplotypes are associated with particular ancestral haplotypes: implications for bone marrow transplantation.
    Christiansen FT; Witt CS; Ciccone E; Pende D; Viale O; Dawkins RL; Moretta L
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1259-60. PubMed ID: 8442107
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of 5-fluorouracil to enhance natural killer activity in rat bone marrow.
    Cramer DV; Harnaha JB; Herberman RB
    Transplant Proc; 1989 Apr; 21(2):3275-6. PubMed ID: 2785307
    [No Abstract]   [Full Text] [Related]  

  • 8. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an inhibitory MHC receptor on alloreactive rat natural killer cells.
    Naper C; Ryan JC; Nakamura MC; Lambracht D; Rolstad B; Vaage JT
    J Immunol; 1998 Jan; 160(1):219-24. PubMed ID: 9551974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I.
    Koike J; Wakao H; Ishizuka Y; Sato TA; Hamaoki M; Seino K; Koseki H; Nakayama T; Taniguchi M
    J Exp Med; 2004 Jan; 199(1):137-44. PubMed ID: 14707119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-interferon modulates the growth of bone marrow progenitors of natural killer cells].
    Migliorati G; Giampietri A; Cannarile L; Ayroldi E; Riccardi C
    G Ital Chemioter; 1985; 32(1):127-30. PubMed ID: 3913613
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands.
    Han M; Fallena M; Guo Y; Stastny P
    Hum Immunol; 2007 Jun; 68(6):507-13. PubMed ID: 17509450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
    Ruggeri L; Capanni M; Urbani E; Perruccio K; Shlomchik WD; Tosti A; Posati S; Rogaia D; Frassoni F; Aversa F; Martelli MF; Velardi A
    Science; 2002 Mar; 295(5562):2097-100. PubMed ID: 11896281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell development and function precede alpha beta T cell differentiation in mouse fetal thymic ontogeny.
    Carlyle JR; Michie AM; Cho SK; Zúñiga-Pflücker JC
    J Immunol; 1998 Jan; 160(2):744-53. PubMed ID: 9580246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunobiology of natural killer cells and bone marrow allograft rejection.
    Barao I; Murphy WJ
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ability of the cells of the regenerating bone marrow to prevent the interaction of natural killer cells with target cells of neoplastic origin].
    Van'ko LV
    Vestn Akad Med Nauk SSSR; 1986; (1):39-42. PubMed ID: 3953145
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
    George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
    J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.